Luis Maria Schang

Professor

Cornell University College of Veterinary Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Luis Maria Schang is a faculty member at Cornell University College of Veterinary Medicine in the United States. His research focuses on epigenetic approaches to viral infections, as indicated by his recent publications on topics such as human DNA viruses, retroviruses, and the management of herpes simplex infections. Additionally, he has contributed to discussions on pandemic antiviral research and the implications of viral load in COVID-19 patients.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Jimmy D. Dikeakos

University of Western Ontario

CANADA

View details

Dominik Wodarz

University of California, San Diego

UNITED STATES

View details

Bruce Banfield

Queen's University

CANADA

View details

Mingyu Qiao

Assistant Professor of Innovation and Entrepreneurship

University of Connecticut

UNITED STATES

View details

Stephen Mark Tompkins

University of Georgia

UNITED STATES

View details

Karl Munger

Tufts University

UNITED STATES

View details

Gary C. Chan

SUNY Upstate Medical University

UNITED STATES

View details

Daniel Depledge

University College London

UNITED KINGDOM

View details

Dohun Pyeon

Associate Professor/Full Professor

Michigan State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luis Maria Schang

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Epigenetic drugs against human DNA viruses and retroviruses

ISAR opinion: Product development partnerships to fund pandemic antiviral research

Histone H2A variant H2A.B is enriched in transcriptionally active and replicating HSV-1 lytic chromatin

Erp57 facilitates ZIKV-induced DNA damage via NS2B/NS3 complex formation

The opportunities and challenges of epigenetic approaches to manage herpes simplex infections

Virology under the Microscope-a Call for Rational Discourse.

Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patients.

Meeting report: 35th international conference on antiviral research in Seattle, WA, USA – March 21–25, 2022

On the Sensitivity of the Virion Envelope to Lipid Peroxidation

Novel chlorine‐extending polymer coating with prolonged antiviral activity against <scp>SARS‐CoV</scp> ‐2

Zika Virus Induces Mitotic Catastrophe in Human Neural Progenitors by Triggering Unscheduled Mitotic Entry in the Presence of DNA Damage While Functionally Depleting Nuclear PNKP

Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City

Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy

Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV-2 dynamics

Patterns of the COVID-19 pandemic spread around the world: exponential versus power laws

Collaborators (9)

Jimmy D. Dikeakos

Dominik Wodarz

Bruce Banfield

Mingyu Qiao

Stephen Mark Tompkins

Karl Munger

Gary C. Chan

Daniel Depledge

Dohun Pyeon

Make your next move.